Onderneming Cytek Biosciences, Inc.
Aandelen
CTKB
US23285D1090
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,3 USD | -2,21% |
|
-5,53% | -41,89% |
12/06 | Cytek Biosciences op zoek naar fusies en overnames | CI |
12/06 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
Vakgebied
Aantal werknemers: 637
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Full Spectrum Flow Cytometry Platform
81,2
%
| 149 | 90,6 % | 157 | 81,2 % | +5,46% |
Service
18,8
%
| 15 | 9,4 % | 36 | 18,8 % | +135,15% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
52,9
%
| 95 | 57,7 % | 102 | 52,9 % | +7,92% |
EMEA
27,6
%
| 44 | 26,8 % | 53 | 27,6 % | +20,97% |
APAC
16,4
%
| 23 | 13,7 % | 32 | 16,4 % | +40,29% |
Other
3,2
%
| 3 | 1,8 % | 6 | 3,2 % | +107,69% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ming Yan
FOU | Founder | 61 | 01-12-14 |
Wen Bin Jiang
FOU | Founder | 60 | 01-12-14 |
Chris Williams
COO | Chief Operating Officer | 55 | 31-10-22 |
Paul Goodson
IRC | Investor Relations Contact | - | - |
Philippe Busque
SAM | Sales & Marketing | 53 | 28-08-23 |
Connie Wedel
HRO | Human Resources Officer | - | - |
Melik Ulusu
PRN | Corporate Officer/Principal | - | 01-01-20 |
Allen Poirson
PRN | Corporate Officer/Principal | 64 | 13-11-18 |
Valerie Barnett
LAW | General Counsel | 49 | 01-01-21 |
Patrik Jeanmonod
PRN | Corporate Officer/Principal | 58 | 01-11-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 73 | 01-06-22 |
Deborah Neff
BRD | Director/Board Member | 71 | - |
Jack Ball
BRD | Director/Board Member | 77 | 13-11-18 |
Allen Poirson
PRN | Corporate Officer/Principal | 64 | 13-11-18 |
Wen Bin Jiang
FOU | Founder | 60 | 01-12-14 |
Ming Yan
FOU | Founder | 61 | 01-12-14 |
Vera Imper
BRD | Director/Board Member | 62 | 31-12-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 131 272 929 | 119 796 512 ( 91,26 %) | 0 | 91,26 % |
Bedrijfsgegevens
![Adres Cytek Biosciences, Inc.(CTKB)](https://cdn.zonebourse.com/static/address/125041252.png)
Sector
Verkoop per activiteit
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,89% | 696 mln. | |
+5,16% | 213 mld. | |
+9,62% | 188 mld. | |
+31,18% | 157 mld. | |
+33,37% | 113 mld. | |
+5,25% | 64,85 mld. | |
+1,51% | 49,1 mld. | |
-4,27% | 38,83 mld. | |
+0,88% | 35,6 mld. | |
+8,44% | 27,4 mld. |
- Beurs
- Aandelen
- Koers CTKB
- Onderneming Cytek Biosciences, Inc.